Trials / Completed
CompletedNCT05878990
Quit & Fit 2.0: Feasibility and Usability Testing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hackensack Meridian Health · Academic / Other
- Sex
- Female
- Age
- 18 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
Pilot randomized controlled trial to compare tobacco cessation rates of two arms: a 6-week culturally tailored tobacco cessation intervention versus a 6-week personalized culturally-tailored tobacco cessation intervention among African American women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Culturally-tailored Tobacco Treatment | Weekly telephone calls with a certified tobacco treatment specialist (CTTS) for 6 weeks. The culturally-tailored tobacco intervention content by week via telephone call with the CTTS includes among others: Reasons and Motivations for Quitting, Benefits of Quitting, Stress Management and Discussion about Environmental Influences. |
| BEHAVIORAL | Culturally-tailored Content Newsletters | Weekly newsletters covering topics such as Race and Smoking, Nicotine Replacement Therapy (NRT) Reasons and Motivations for Quitting, Benefits of Quitting and other related topics. |
| BEHAVIORAL | Control Preference Scale | Survey to elicit preference on the decision-making interaction with healthcare provider. The survey uses a 5 point scale from 1 to 5 with 1 or 2 points representing Active Control Preference; 3 or 4 representing a Collaborative Control Preference and 5 representing a Passive Control Preference. |
| BEHAVIORAL | Active Content Newsletter or Passive Content Newsletter | Based on the answers to the Control Preference Scale, participants will receive the appropriate weekly newsletter (active content or passive content). Newsletters are covering topics such as Race and Smoking, Nicotine Replacement Therapy (NRT) Reasons and Motivations for Quitting, Benefits of Quitting and other related topics presented in a more passive or active manner. |
Timeline
- Start date
- 2023-04-05
- Primary completion
- 2024-04-30
- Completion
- 2024-04-30
- First posted
- 2023-05-30
- Last updated
- 2024-10-17
- Results posted
- 2024-10-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05878990. Inclusion in this directory is not an endorsement.